For research use only. Not for therapeutic Use.
RR6 (CAT: I001353) is indeed a selective, reversible, and competitive inhibitor of vanin, an enzyme involved in cellular metabolism. Oral administration of RR6 has been shown to effectively inhibit vanin activity in rats, leading to alterations in plasma lipid concentrations during fasting. This highlights the potential utility of RR6 as a tool compound in chemical biology research, particularly in the study of van in-mediated metabolic pathways.
Catalog Number | I001353 |
CAS Number | 1351758-37-6 |
Synonyms | (2R)-2,4-dihydroxy-3,3-dimethyl-N-(3-oxo-4-phenylbutyl)butanamide |
Molecular Formula | C16H23NO4 |
Purity | ≥95% |
Target | vanin |
Solubility | 10 mM in DMSO |
Storage | Store at -20°C |
IUPAC Name | (2R)-2,4-dihydroxy-3,3-dimethyl-N-(3-oxo-4-phenylbutyl)butanamide |
InChI | InChI=1S/C16H23NO4/c1-16(2,11-18)14(20)15(21)17-9-8-13(19)10-12-6-4-3-5-7-12/h3-7,14,18,20H,8-11H2,1-2H3,(H,17,21)/t14-/m0/s1 |
InChIKey | PTVUGLNOPRZQEY-AWEZNQCLSA-N |
SMILES | CC(C)(CO)C(C(=O)NCCC(=O)CC1=CC=CC=C1)O |
Reference | <p style=”/line-height:25px/”> |